Literature DB >> 11642512

Soluble interleukin-2 receptor in Sjögren's syndrome: relation to main serum immunological and immunohistochemical parameters.

A Spadaro1, V Riccieri, G Benfari, M Scillone, E Taccari.   

Abstract

Our aim was to study sIL-2R relationship with main serum immunological and LSG immunohistochemical parameters, including surface antigen expression of immune activation, in 27 patients with primary SS. Serum sIL-2R levels were significantly higher in SS (p<0.00005), as well as in SLE (p<0.05) and RA (p< 0.000001) patients than in controls. In SS patients with abnormal slL-2R values (n = 7) we found higher levels of anti-SSB/La antibodies (p<0.05), IgM-RF (p<0.014) and CRP (p<0.003) with respect to those with normal sIL-2R values (n = 20). Moreover, sIL-2R levels correlated positively with those of anti-SSB/La antibodies (p<0.0037) and with CRP (p<0.008). The comparison of groups with (A) and without (B) abnormal slL-2R levels reveals a statistically different percentage of patients with foci number > 1 (86% vs 40%; p <0.047), and CD25 expression on lymphocytes (100% vs 40%; p < 0.008). The frequency (p < 0.025) of CD25 expression on lymphocytes was higher in group A than in group B. The frequency of CD25 expression on the infiltrates correlated not only with sIL-2R levels (p<0.047), but also with anti-SSB/La antibody values (p < 0.044), with Tarpley histological classes (p < 0.009) and with frequency of HLA-DR expression on lymphocytes (p<0.004) and on epithelial cells (p<0.002). The frequency of epithelial CD25 expression also correlated with that of epithelial HLA-DR (p<0.004). Our report suggests that slL-2R is linked to glandular involvement in primary SS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11642512     DOI: 10.1007/s100670170020

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  3 in total

1.  Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.

Authors:  Maike Jülich; Anna-Maria Kanne; Bettina Sehnert; Stephan Budweiser; Reinhard E Voll; Florian Kollert
Journal:  Clin Rheumatol       Date:  2018-06-01       Impact factor: 2.980

2.  Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9.

Authors:  Cintia S De Paiva; Kyung-Chul Yoon; Solherny B Pangelinan; Sapa Pham; Larry M Puthenparambil; Eliseu Y Chuang; William J Farley; Michael E Stern; De-Quan Li; Stephen C Pflugfelder
Journal:  J Inflamm (Lond)       Date:  2009-10-31       Impact factor: 4.981

3.  Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren's syndrome.

Authors:  Magdalena Keindl; Richard Davies; Brith Bergum; Johan G Brun; Daniel Hammenfors; Roland Jonsson; Valeriya Lyssenko; Silke Appel
Journal:  Arthritis Res Ther       Date:  2022-05-07       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.